000 | 01909 a2200553 4500 | ||
---|---|---|---|
005 | 20250516215155.0 | ||
264 | 0 | _c20161213 | |
008 | 201612s 0 0 eng d | ||
022 | _a1521-0464 | ||
024 | 7 |
_a10.3109/10717544.2014.916769 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPatil, Nilam H | |
245 | 0 | 0 |
_aInsulin-loaded alginic acid nanoparticles for sublingual delivery. _h[electronic resource] |
260 |
_bDrug delivery _c2016 |
||
300 |
_a429-36 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdhesiveness |
650 | 0 | 4 | _aAdministration, Sublingual |
650 | 0 | 4 |
_aAlginates _xchemistry |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
650 | 0 | 4 | _aCalorimetry, Differential Scanning |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 | _aCircular Dichroism |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xblood |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 |
_aGlucuronic Acid _xchemistry |
650 | 0 | 4 |
_aHexuronic Acids _xchemistry |
650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 |
_aInsulin _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMouth Mucosa _xmetabolism |
650 | 0 | 4 | _aNanoparticles |
650 | 0 | 4 | _aNanotechnology |
650 | 0 | 4 |
_aNiacinamide _xchemistry |
650 | 0 | 4 | _aOral Mucosal Absorption |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 | _aPermeability |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aSpectroscopy, Fourier Transform Infrared |
650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
700 | 1 | _aDevarajan, Padma V | |
773 | 0 |
_tDrug delivery _gvol. 23 _gno. 2 _gp. 429-36 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10717544.2014.916769 _zAvailable from publisher's website |
999 |
_c23891924 _d23891924 |